Drugs / FSH-GEX™
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01477073 | Oct 2011 → Apr 2012 | female infertility | Glycotope GmbH | Completed | No outcome recorded |
| Phase 1 | NCT01354886 | Apr → Oct 2011 | female infertility | Glycotope GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSH-GEX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01477073 ↗ |
| Modality | Protein / enzyme biologic | “novel recombinant human FSH” PMID 28591833 ↗ Aug 2017 |
| Route | Subcutaneous | “FSH-GEX(TM) Administered Subcutaneously” NCT01477073 ↗ |